FTSE China A50 Index Quarterly Adjustment: Including BeiGe-Shenzhou-U (688235.SH), Pharmaceutical Kangde (603259.SH), excluding China Nuclear Power (601985.SH), etc.

Zhitongcaijing · 09/03/2025 10:17

The Zhitong Finance App learned that on September 3, FTSE Russell announced quarterly review changes to the FTSE China 50 Index, FTSE China A50 Index, etc. The change will take effect when trading closes on Friday September 19, 2025 (that is, Monday, September 22, 2025). Among them, the FTSE China A50 Index included A-shares such as BeiGe-Shenzhou-U (688235.SH), Xinyisheng (300502.SZ), Yao Ming Kangde (603259.SH), and Zhongji Xuchuang (300308.SZ); A shares such as China Nuclear Power (601985.SH), China Unicom (), Guodian Nanrui (US), and Wanhua Chemical (Sichuan) were removed. 600050.SH 600406.SH 600309.SH The list of alternative stocks is: Minsheng Bank (600016.SH), Luoyang Molybdenum (603993.SH), Tonghuashun (300033.SZ), SAIC Motor Group (600104.SH), and Cyrus (). 601127.SH

According to information, the FTSE China A50 Index is an important reference for overseas investors , Judging from the historical experience of index adjustments , FTSE China's A50 index adjustments often attract large amounts of passive capital from overseas.

Also, the FTSE China 50 Index list has not changed; only Hong Kong stocks such as China Hongqiao (01378), Hanson Pharmaceuticals (03692), Huatai Securities (06886), JD Health (06618), and Xinhua Insurance (01336).